If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNT.L Regulatory News (HNT)

  • There is currently no data for HNT

Trading Update

17 Dec 2019 07:00

RNS Number : 0634X
Huntsworth PLC
17 December 2019
 

 

17 December 2019

Trading Update

 

Huntsworth plc ("Huntsworth or the "Group"), the international healthcare and communications group, today issues a trading update for the 11 months to 30 November 2019.

 

·;

Group trading satisfactory, within market expectations

 

·;

Return to growth in Marketing

 

·;

Acquisitions successfully integrated and performing in line with expectations

 

·;

Cash flow strong and gearing expected to fall to c.1.6x at the year-end

 

 

Current Trading

The Group anticipates like-for-like revenue growth of c. 3% for the full year, with a small impact on margin as a result of investments in property and talent, and expects to report headline profit before tax within current market expectations* for the year to 31 December 2019.

As expected, the Marketing division saw an acceleration of growth over the second half of the year, although client-led project deferrals and product closures limited the level of growth to c. 3% across the half. Project wins were good, and the pipeline of opportunities is strong, especially in multi-service requirements where the additional capabilities of acquired businesses can be deployed, indicating further improvement and good prospects for 2020.

There was further good growth in the Medical division leading to c. 8% like-for-like growth for the full year. The Immersive division performed well against very strong comparatives and has secured a number of new mandates which indicate good growth prospects for 2020, although the cost of securing these mandates impacted profits.

The Communications division saw an acceleration of growth in the second half and will achieve full year revenue growth of c. 2% for the first time in several years.

 

Financial Position

The Group remains in a strong financial position, operating well within its £130m facility, and expects year end leverage to be c. 1.6x net debt to pro forma EBITDA**.

  

Outlook

The Group remains focused on delivering superior growth led by its healthcare agencies and recent acquisitions continue to complement this. Despite some currency headwinds as a result of the strengthening in sterling, management is confident about the Group's future trading and expects continued good growth across all of its businesses in 2020.

 

* Market expectations of Headline PBT range from £38.5m to £41.0m

** Pro forma EBITDA takes into account a full year's contribution from acquisitions made during 2019. Leverage is on a pre-IFRS 16 basis.

 

 

 Enquiries

 

 

Citigate Dewe Rogerson

020 7638 9571

Angharad Couch

Nick Reading

Elizabeth Kittle

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGGGGPPUPBGBQ
Date   Source Headline
14th Dec 20122:22 pmRNSBoard Changes
3rd Dec 20123:41 pmRNSBlocklisting Interim Review
3rd Dec 20123:37 pmRNSTotal Voting Rights
15th Nov 20127:00 amRNSInterim Management Statement
14th Nov 20123:20 pmRNSDirector/PDMR Shareholding
7th Nov 201212:40 pmRNSAdditional Listing
22nd Oct 20123:55 pmRNSHolding(s) in Company
11th Oct 201210:03 amRNSScrip Dividend Alternative
25th Sep 20124:32 pmRNSHolding(s) in Company
3rd Sep 201211:32 amRNSTotal Voting Rights
24th Aug 201210:16 amRNSHolding(s) in Company
17th Aug 201211:06 amRNSAdditional Listing
15th Aug 20127:00 amRNSInterim Results
9th Aug 20127:00 amRNSNotice of Results
1st Aug 20129:08 amRNSTotal Voting Rights
30th Jul 201211:58 amRNSHolding(s) in Company
13th Jul 20125:29 pmRNSTransaction in Own Shares
6th Jul 201211:21 amRNSDirector/PDMR Shareholding
5th Jul 20127:00 amRNSDirectorate Change
5th Jul 20127:00 amRNSDirectorate Change
3rd Jul 20129:47 amRNSAdditional Listing
29th Jun 201211:30 amRNSShare Buy-back Programme
11th Jun 201211:52 amRNSScrip Dividend Alternative
1st Jun 20129:57 amRNSBlocklisting Interim Review
18th May 201211:16 amRNSResult of AGM
18th May 20127:00 amRNSAppointment of Non-Executive Director
18th May 20127:00 amRNSInterim Management Statement
2nd May 201210:34 amRNSAnnual Information Update
18th Apr 20129:07 amRNSNotice of AGM
4th Apr 20129:00 amRNSDirector/PDMR Shareholding
3rd Apr 20127:00 amRNSPreliminary Results
1st Feb 20129:30 amRNSTotal Voting Rights
31st Jan 20122:05 pmRNSDirector/PDMR Shareholding
31st Jan 20127:00 amRNSPre Close Trading Statement
11th Jan 20127:00 amRNSTransaction in Own Shares
4th Jan 20129:18 amRNSTotal Voting Rights
21st Dec 20117:00 amRNSTransaction in Own Shares
20th Dec 20117:00 amRNSTransaction in Own Shares
19th Dec 20117:00 amRNSTransaction in Own Shares
15th Dec 20117:00 amRNSTransaction in Own Shares
14th Dec 20117:00 amRNSTransaction in Own Shares
5th Dec 20117:00 amRNSTransaction in Own Shares
2nd Dec 20117:00 amRNSTransaction in Own Shares
1st Dec 20119:28 amRNSBlocklisting Interim Review
1st Dec 20119:25 amRNSTotal Voting Rights
1st Dec 20117:00 amRNSTransaction in Own Shares
29th Nov 20117:00 amRNSTransaction in Own Shares
25th Nov 20117:00 amRNSTransaction in Own Shares
24th Nov 201110:00 amRNSAmendment: Transaction in Own Shares
24th Nov 20119:15 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.